Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Indaptus Therapeutics, Inc.

Pharmaceutical Preparations · New York, NY, United States

  1. PrincipalsJeffrey A MecklerCo-Chief Executive OfficerNir SassiChief Financial OfficerWalt Addison LinscottChief Operating Officerand 6 more
  2. CompanyIndaptus Therapeutics, Inc.New York, NY, United States
  3. Phone line+1 (646) 427-2727General business
Request a quote

Indaptus Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker INDP) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 9

Chief executive

Jeffrey A MecklerCo-Chief Executive Officer

Chair & board

Avraham Ben-TzviDirector (Board)
David E. LazarDirector (Board)
David NatanDirector (Board)
Jerome D JabbourDirector (Board)

Finance

Nir SassiChief Financial Officer

Operations

Walt Addison LinscottChief Operating Officer
Everyone else on file (1)
Michael James NewmanCSO and Director

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Jeffrey A Meckler — Co-Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Nir Sassi — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Walt Addison Linscott — Chief Operating Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Michael James Newman — CSO and Director

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers